Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY11.81 CNY
Change Today +0.25 / 2.16%
Volume 17.7M
As of 3:05 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

harbin pharmaceutical grp-a (600664) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/17/15 - CNY17.20
52 Week Low
08/4/14 - CNY6.47
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HARBIN PHARMACEUTICAL GRP-A (600664)

Related News

No related news articles were found.

harbin pharmaceutical grp-a (600664) Related Businessweek News

No Related Businessweek News Found

harbin pharmaceutical grp-a (600664) Details

Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and trading of pharmaceutical in China and internationally. The company offers antibiotics, small-molecular drug preparations, OTC and healthcare products, modern Chinese medicines, biopharmaceuticals, animal vaccines, and medicine circulations under the Hongyan Yaopin, Guangwei, Renmin Tongtai, Hayao Shengwu, Baohulu, Manshanhong, Hutong, Hayaoliu, Gaizhonggai, Sanchine, Shiyitang, and Hayao brands. Its APIs include penicillin, cephalosporin, and intermediates. Harbin Pharmaceutical Group Co., Ltd. is based in Harbin, China.

harbin pharmaceutical grp-a (600664) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharmaceutical grp-a (600664) Key Developments

Harbin Pharmaceutical Group Co., Ltd.(SHSE:600664) dropped from CSI 300 Index

Harbin Pharmaceutical Group Co., Ltd. will be removed from CSI 300.

Harbin Pharmaceutical Group Co., Ltd. to Report Q1, 2015 Results on Apr 30, 2015

Harbin Pharmaceutical Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 30, 2015

Harbin Pharmaceutical Group Co., Ltd. Announces Earnings Results for the First Quarter of 2015

Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter of 2015. For the quarter the company reported basic earnings per share CNY 0.08 and weighted average return on net assets 1.93%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600664:CH CNY11.81 CNY +0.25

600664 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.01 USD -0.002
Kirin Holdings Co Ltd ¥1,909 JPY +24.50
Roche Holding AG SFr.279.10 CHF +0.40
View Industry Companies

Industry Analysis


Industry Average

Valuation 600664 Industry Range
Price/Earnings 95.8x
Price/Sales 1.5x
Price/Book 2.8x
Price/Cash Flow 95.1x
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARMACEUTICAL GRP-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at